An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract

Ailun Tseng, Chih Hsueh Yang, Chih Hao Chen, Chang Han Chen, Shih Lan Hsu, Mei Hsien Lee, Hoong Chien Lee, Li Jen Su

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The fact that many chemotherapeutic drugs cause chemoresistance and side effects during the course of colorectal cancer treatment necessitates development of novel cytotoxic agents aiming to attenuate new molecular targets. Here, we show that Astragalus membranaceus (Fischer) Bge. var. mongolicus (Bge.) Hsiao (AM), a traditional Chinese medicine, can inhibit tumor growth in vivo and elucidate the underlying molecular mechanisms. The antitumor effect of AM was assessed on the subcutaneous tumors of human colorectal cancer cell line HCT116 grafted into nude mice. The mice were treated with either water or 500 mg/kg AM once per day before being sacrificed for extraction of tumors, which were then subjected to microarray expression profiling. The gene expression of the extraction was then profiled using microarray analysis. The identified genes differentially expressed between treated mice and controls reveal that administration of AM suppresses chromosome organization, histone modification and regulation of macromolecule metabolic process. A separate analysis focused on differentially expressed microRNAs revealing involvement of macromolecule metabolism, and intracellular transport, as well as several cancer signaling pathways. For validation, the input of the identified genes to The Library of Integrated Network-based Cellular Signatures led to many chemopreventive agents of natural origin that produce similar gene expression profiles to that of AM. The demonstrated effectiveness of AM suggests a potential therapeutic drug for colorectal cancer.

Original languageEnglish
Pages (from-to)659-668
Number of pages10
JournalOncology Reports
Volume35
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Astragalus membranaceus
Colorectal Neoplasms
Neoplasms
Histone Code
Chinese Traditional Medicine
Cytotoxins
Microarray Analysis
MicroRNAs
Transcriptome
Nude Mice
Pharmaceutical Preparations
Genes
Libraries
Chromosomes
Gene Expression
Cell Line
Water
Therapeutics
Growth

Keywords

  • Colorectal cancer
  • Microarray
  • MicroRNA
  • Xenograft Astragalus membranaceus

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract. / Tseng, Ailun; Yang, Chih Hsueh; Chen, Chih Hao; Chen, Chang Han; Hsu, Shih Lan; Lee, Mei Hsien; Lee, Hoong Chien; Su, Li Jen.

In: Oncology Reports, Vol. 35, No. 2, 01.02.2016, p. 659-668.

Research output: Contribution to journalArticle

Tseng, Ailun ; Yang, Chih Hsueh ; Chen, Chih Hao ; Chen, Chang Han ; Hsu, Shih Lan ; Lee, Mei Hsien ; Lee, Hoong Chien ; Su, Li Jen. / An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract. In: Oncology Reports. 2016 ; Vol. 35, No. 2. pp. 659-668.
@article{381bd30c75174cbd9fef9c0e7195129b,
title = "An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract",
abstract = "The fact that many chemotherapeutic drugs cause chemoresistance and side effects during the course of colorectal cancer treatment necessitates development of novel cytotoxic agents aiming to attenuate new molecular targets. Here, we show that Astragalus membranaceus (Fischer) Bge. var. mongolicus (Bge.) Hsiao (AM), a traditional Chinese medicine, can inhibit tumor growth in vivo and elucidate the underlying molecular mechanisms. The antitumor effect of AM was assessed on the subcutaneous tumors of human colorectal cancer cell line HCT116 grafted into nude mice. The mice were treated with either water or 500 mg/kg AM once per day before being sacrificed for extraction of tumors, which were then subjected to microarray expression profiling. The gene expression of the extraction was then profiled using microarray analysis. The identified genes differentially expressed between treated mice and controls reveal that administration of AM suppresses chromosome organization, histone modification and regulation of macromolecule metabolic process. A separate analysis focused on differentially expressed microRNAs revealing involvement of macromolecule metabolism, and intracellular transport, as well as several cancer signaling pathways. For validation, the input of the identified genes to The Library of Integrated Network-based Cellular Signatures led to many chemopreventive agents of natural origin that produce similar gene expression profiles to that of AM. The demonstrated effectiveness of AM suggests a potential therapeutic drug for colorectal cancer.",
keywords = "Colorectal cancer, Microarray, MicroRNA, Xenograft Astragalus membranaceus",
author = "Ailun Tseng and Yang, {Chih Hsueh} and Chen, {Chih Hao} and Chen, {Chang Han} and Hsu, {Shih Lan} and Lee, {Mei Hsien} and Lee, {Hoong Chien} and Su, {Li Jen}",
year = "2016",
month = "2",
day = "1",
doi = "10.3892/or.2015.4441",
language = "English",
volume = "35",
pages = "659--668",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract

AU - Tseng, Ailun

AU - Yang, Chih Hsueh

AU - Chen, Chih Hao

AU - Chen, Chang Han

AU - Hsu, Shih Lan

AU - Lee, Mei Hsien

AU - Lee, Hoong Chien

AU - Su, Li Jen

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The fact that many chemotherapeutic drugs cause chemoresistance and side effects during the course of colorectal cancer treatment necessitates development of novel cytotoxic agents aiming to attenuate new molecular targets. Here, we show that Astragalus membranaceus (Fischer) Bge. var. mongolicus (Bge.) Hsiao (AM), a traditional Chinese medicine, can inhibit tumor growth in vivo and elucidate the underlying molecular mechanisms. The antitumor effect of AM was assessed on the subcutaneous tumors of human colorectal cancer cell line HCT116 grafted into nude mice. The mice were treated with either water or 500 mg/kg AM once per day before being sacrificed for extraction of tumors, which were then subjected to microarray expression profiling. The gene expression of the extraction was then profiled using microarray analysis. The identified genes differentially expressed between treated mice and controls reveal that administration of AM suppresses chromosome organization, histone modification and regulation of macromolecule metabolic process. A separate analysis focused on differentially expressed microRNAs revealing involvement of macromolecule metabolism, and intracellular transport, as well as several cancer signaling pathways. For validation, the input of the identified genes to The Library of Integrated Network-based Cellular Signatures led to many chemopreventive agents of natural origin that produce similar gene expression profiles to that of AM. The demonstrated effectiveness of AM suggests a potential therapeutic drug for colorectal cancer.

AB - The fact that many chemotherapeutic drugs cause chemoresistance and side effects during the course of colorectal cancer treatment necessitates development of novel cytotoxic agents aiming to attenuate new molecular targets. Here, we show that Astragalus membranaceus (Fischer) Bge. var. mongolicus (Bge.) Hsiao (AM), a traditional Chinese medicine, can inhibit tumor growth in vivo and elucidate the underlying molecular mechanisms. The antitumor effect of AM was assessed on the subcutaneous tumors of human colorectal cancer cell line HCT116 grafted into nude mice. The mice were treated with either water or 500 mg/kg AM once per day before being sacrificed for extraction of tumors, which were then subjected to microarray expression profiling. The gene expression of the extraction was then profiled using microarray analysis. The identified genes differentially expressed between treated mice and controls reveal that administration of AM suppresses chromosome organization, histone modification and regulation of macromolecule metabolic process. A separate analysis focused on differentially expressed microRNAs revealing involvement of macromolecule metabolism, and intracellular transport, as well as several cancer signaling pathways. For validation, the input of the identified genes to The Library of Integrated Network-based Cellular Signatures led to many chemopreventive agents of natural origin that produce similar gene expression profiles to that of AM. The demonstrated effectiveness of AM suggests a potential therapeutic drug for colorectal cancer.

KW - Colorectal cancer

KW - Microarray

KW - MicroRNA

KW - Xenograft Astragalus membranaceus

UR - http://www.scopus.com/inward/record.url?scp=84954306603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954306603&partnerID=8YFLogxK

U2 - 10.3892/or.2015.4441

DO - 10.3892/or.2015.4441

M3 - Article

C2 - 26719057

AN - SCOPUS:84954306603

VL - 35

SP - 659

EP - 668

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 2

ER -